Cochrane Database Syst Rev
July 2008
Background: Corticosteroids remain the mainstay of treatment in idiopathic nephrotic syndrome, including focal and segmental glomerulosclerosis (FSGS). However, only about 20% of patients with FSGS experience a partial or complete remission of nephrotic syndrome despite treatment.
Objectives: To assess the effects of different immunomodulatory and immunosuppressive regimes in adults with FSGS.
Folia Haematol Int Mag Klin Morphol Blutforsch
October 1974
Pharm Zentralhalle Dtschl
May 1966